Oral contraceptives: side effects and depression in adolescent girls

Contraception

Volumn 75, Issue 4, 2007, Pages 299-304

  O'Connell, Katharine ^a   Davis, Anne R ^a   Kerns, Jennifer ^a  

^a Columbia University ^*  (United States)

Author keywords

Adolescents; Depression; Oral contraceptives; Side effects

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; PLACEBO;

ABDOMINAL PAIN; ACNE; ADOLESCENT; ARTICLE; BACKACHE; BLOATING; BREAST HYPERTROPHY; BREAST TENDERNESS; CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; DYSMENORRHEA; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERACTIVITY; INCREASED APPETITE; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; MOOD CHANGE; NAUSEA; PREMENSTRUAL SYNDROME; PSYCHIATRIC DIAGNOSIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SCREENING TEST; SELF EVALUATION; SIDE EFFECT; TREATMENT DURATION; VOMITING; WEIGHT GAIN;

ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; UNITED STATES;

EID: 33847727069     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.09.008     Document Type: Article

References (39)

1. Rosenberg M.J., and Waugh M.S. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 179 (1998) 577-582
2. Centers for Disease Control and Prevention, and National Center for Health Statistics. Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth (1997) [Series 23, No. 19, PHS No. 97-1995]
3. Oakley D., Sereika S., and Bogue E.L. Oral contraceptive pill use after an initial visit to a family planning clinic. Fam Plann Perspect 23 (1991) 150-154
4. Emans S.J., Grace E., Woods E.R., Smith D.E., Klein K., and Merola J. Adolescents' compliance with the use of oral contraceptives. JAMA 257 (1987) 3377-3381
5. Berenson A.B., and Wiemann C.M. Contraceptive use among adolescent mothers at 6 months postpartum. Obstet Gynecol 89 (1997) 999-1005
6. Moore P.J., Adler N.E., and Kegeles S.M. Adolescents and the contraceptive pill: the impact of beliefs on intentions and use. Obstet Gynecol 88 (1996) 48S-56S
7. Blumenthal P.D., Wilson L.E., Remsburg R.E., Cullins V.E., and Huggins G.R. Contraceptive outcomes among postpartum and post-abortal adolescents. Contraception 50 (1994) 451-460
8. In: Stenchever M.A., Herbst A.L., Droegemueller W., and Mishell D. (Eds). Comprehensive gynecology (2001), Elsevier Health Sciences, St. Louis (MO) 309 [chapter 12]
9. Redmond G., Godwin A.J., Olson W., and Lippman J.S. Use of placebo controls in an oral contraceptive trial: methodological issues and adverse event incidence. Contraception 60 (1999) 81-85
10. Goldzieher J.W., Moses L.E., Averkin E., Scheel C., and Taber B.Z. A placebo-controlled double-blind crossover investigation of the side effects attributed to oral contraceptives. Fertil Steril 22 (1971) 609-623
11. Coney P., Washenik K., Langley R.G.B., DiGiovanna J.J., and Harrison D.D. Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials. Contraception 63 (2001) 297-302
12. Almagor M., and Ben-Porath M.S. Mood changes during the menstrual cycle and their relation to the use of oral contraceptives. J Psychosom Res 35 (1991) 721-728
13. Walker A., and Bancroft J. Relationship between premenstrual symptoms and oral contraceptive use: a controlled study. Psychosom Med 52 (1990) 86-96
14. Rosenthal S.L., Cotton S., Ready J.N., Potter L.S., and Succop P.A. Adolescents' attitudes and experiences regarding levonorgestrel 100 mcg/ethinyl estradiol 20 mcg. J Pediatr Adolesc Gynecol 15 (2002) 301-305
15. Risser W.L., Gefter L.R., Barratt M.S., et al. Weight change in adolescents who used hormonal contraception. J Adolesc Health 24 (1999) 433
16. Davis A.R., Westhoff C.L., O'Connell K.J., et al. Oral contraceptives for dysmenorrhea in adolescent girls: a placebo-controlled randomized trial. Obstet Gynecol 106 (2005) 97-104
17. Hillen T.I., Grbavac S.L., Johnston P.J., et al. Primary dysmenorrhea in young Western Australian women: prevalence, impact, and knowledge of treatment. J Adolesc Health 25 (1999) 40-45
18. Moos R.H. Menstrual Distress Questionnaire manual (1991), Western Psychological Services, Los Angeles (Calif)
19. McDowell I., and Newell C. Measuring health: a guide to rating scales and questionnaires (1996), Oxford University Press, New York
20. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1 (1977) 385-401
21. Blascovich J., and Tomaka J. Measures of self-esteem. In: Robinson J.P., Shaver J.R., and Wrightsman L.S. (Eds). Measures of personality and social psychological attitudes (1991), Academic Press, San Diego (CA) 115-160
22. Buckelew S.P., Parker J.C., Keefe F.J., et al. Self-efficacy and pain behavior among subjects with fibromyalgia. Pain 59 (1994) 377-384
23. Davis A.R., and Teal S.B. Controversies in adolescent hormonal contraception. Infertil Reprod. Med Clin North Am 14 (2003) 141-156
24. Barsky A.J., Saintfort R., Rogers M.P., and Borus J.F. Nonspecific medication side effects and the Nocebo phenomenon. JAMA 287 (2002) 622-627
25. Myers M.G., Cairns J.A., and Singer J. The consent form as a possible cause of side effects. Clin Pharmacol Ther 42 (1987) 250-253
26. Gallo M.F., Grimes D.A., Schultz K.F., and Helmerhorst F.M. Combination estrogen-progestin contraceptives and body weight: systematic review of randomized controlled trials. Obstet Gynecol 103 (2004) 359-373
27. Nilsson A., and Almgren P.E. Psychiatric symptoms during the post-partum period as related to use of oral contraceptives. Br Med J 2 (1968) 453-455
28. Herzberg B.N., Johnson A.L., and Brown S. Depressive symptoms and oral contraceptives. Br Med J 4 (1970) 142-145
29. Worsley A., and Chang A. Oral contraceptives and emotional state. J Psychosom Res 22 (1978) 13-16
30. Joffe H., Cohen L., and Harlow B. Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration. Am J Obstet Gynecol 189 (2003) 1523-1530
31. Rosenberg M., and Waugh M. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 179 (1998) 577-582
32. Bancroft J., and Rennie D. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms. J Psychosom Res 37 (1993) 195-202
33. Maes M., Claes M., Schotte C., et al. Disturbances in dexamethasone suppression test and lower availability of l-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy. J Psychosom Res 36 (1992) 191-197
34. Rasgon N.L., Rao R.C., Hwang S., et al. Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J Affect Disord 74 (2003) 299-304
35. Graham C.A., and Sherwin B.B. The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms. Psychoneuroendocrinology 18 (1993) 273-281
36. Garrison C.Z., Addy C.L., Jacksosn K.L., et al. The CES-D as a screen for depression and other psychiatric disorders in adolescents. J Am Acad Child Adolesc Psychiatry 30 (1991) 636-641
37. Pumariega A.J., Johnson N.P., Sheridan D., et al. The influence of race and gender on depressive and substance abuse symptoms in high-risk adolescents. Cult Divers Ment Health 2 (1996) 115-123
38. Prescott C.A., McArdle J.J., Hishinuma E.S., et al. Prediction of major depression and dysthymia from CES-D scores among ethnic minority adolescents. J Am Acad Child Adolesc Psychiatry 37 (1998) 495-503
39. Thomas J.L., Nones G.N., Scarinci I.C., et al. The utility of the CES-D as a depression screening measure among low-income women attending primary care clinics. Int J Psychiatry Med 31 (2001) 25-40